Literature DB >> 1969960

Interrelationships between serologic markers of immune activation and T lymphocyte subsets in HIV infection.

H E Prince1, S Kleinman, C Czaplicki, J John, A E Williams.   

Abstract

Relationships among four serologic activation markers and T cell subsets were measured in HIV-seropositive former blood donors (N = 64) and seronegative controls (N = 61). Significant correlations were observed for the HIV group in pairwise comparisons of soluble IL-2 receptor (sIL-2R), beta 2-microglobulin (beta 2M), neopterin (NEOP), and soluble CD8 (sCD8). CD4 cell levels (number/microliter) in the HIV group showed significant negative correlation with all four serologic markers; CD8 cell levels, in contrast, showed no significant correlation with any serologic activation marker measured. Significant correlations were observed, however, among various cell surface activation markers and serologic activation markers. Specifically, the proportion of CD8 cells expressing CD45RA showed significant negative correlations with NEOP and B2M levels, whereas the proportion of CD8 cells expressing HLA-DR showed significant positive correlations with B2M and sIL-2R levels. Further, the proportion of CD8 cells expressing CD38 showed significant positive correlations with all four serologic activation markers. These findings indicate that sIL-2R, B2M, NEOP, and sCD8 show similar quantitative changes and correlational relationships to CD4 cell destruction in HIV infection; they differ, however, in their relationships to proportional changes in activated CD8 cell subsets.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969960

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  11 in total

1.  CD8 T lymphocyte subset markers and HIV infection.

Authors:  A G Bird; K C Watret
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

2.  Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.

Authors:  J L Riley; B L Levine; N Craighead; T Francomano; D Kim; R G Carroll; C H June
Journal:  J Virol       Date:  1998-10       Impact factor: 5.103

3.  Correlation of the percentage of activated, CD3 + DR + lymphocytes to serum neopterin level in HIV-seropositive haemophiliacs.

Authors:  K Pálóczi; E Ujhelyi; D Fuchs; R Mihalik; D Bánhegyi; S Berkessy; V Salavecz; H Wachter; S R Hollán; G Füst
Journal:  Klin Wochenschr       Date:  1991-02-26

4.  Relation of impaired lymphocyte proliferative function to other major human immunodeficiency virus type 1-induced immunological changes.

Authors:  H Z Bass; J L Fahey; P Nishanian; R Detels; W Cumberland; M Kemeny; S Plaeger
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

5.  Simian immunodeficiency virus containing mutations in N-terminal tyrosine residues and in the PxxP motif in Nef replicates efficiently in rhesus macaques.

Authors:  S Carl; A J Iafrate; S M Lang; N Stolte; C Stahl-Hennig; K Mätz-Rensing; D Fuchs; J Skowronski; F Kirchhoff
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  Soluble tumour necrosis factor receptors (sTNF-R) and HIV infection: correlation to CD8+ lymphocytes.

Authors:  A Kalinkovich; G Livshits; H Engelmann; N Harpaz; R Burstein; M Kaminsky; D Wallach; Z Bentwich
Journal:  Clin Exp Immunol       Date:  1993-09       Impact factor: 4.330

7.  The significance of activation markers on CD8 lymphocytes in human immunodeficiency syndrome: staging and prognostic value.

Authors:  M Levacher; F Hulstaert; S Tallet; S Ullery; J J Pocidalo; B A Bach
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

8.  Altered representation of naive and memory CD8 T cell subsets in HIV-infected children.

Authors:  R L Rabin; M Roederer; Y Maldonado; A Petru; L A Herzenberg; L A Herzenberg
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  CD8 naive T cell counts decrease progressively in HIV-infected adults.

Authors:  M Roederer; J G Dubs; M T Anderson; P A Raju; L A Herzenberg; L A Herzenberg
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

Review 10.  Markers predicting progression of human immunodeficiency virus-related disease.

Authors:  C M Tsoukas; N F Bernard
Journal:  Clin Microbiol Rev       Date:  1994-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.